Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery

Name: Capecitabine Plus Pembrolizumab in Patients With Triple Negative Breast Cancer After Chemo-immunotherapy and Surgery
License: Public Domain

UNICANCER

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

triple negative breast neoplasms

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 383568
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.